Aisling Capital Management LP

Holdings History for Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

Symbol: ACRS on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.27%	0%	$1,307,710	434,455	0		$3.01	Q4 2025
30 Sep 2025	0.18%	0%	$825,465	434,455	0		$1.90	Q3 2025
30 Jun 2025	0.17%	0%	$616,926	434,455	0		$1.42	Q2 2025
31 Mar 2025	0.23%	0%	$664,716	434,455	0		$1.53	Q1 2025
31 Dec 2024	0.38%	0%	$1,077,448	434,455	0		$2.48	Q4 2024
30 Sep 2024	0.19%	0%	$499,623	434,455	0		$1.15	Q3 2024
30 Jun 2024	0.21%	0%	$477,901	434,455	0		$1.10	Q2 2024
31 Mar 2024	0.18%	0%	$538,724	434,455	0		$1.24	Q1 2024
31 Dec 2023	0.14%	0%	$456,178	434,455	0		$1.05	Q4 2023
30 Sep 2023	1.2%	0%	$2,976,017	434,455	0		$6.85	Q3 2023
30 Jun 2023	2.2%	0%	$4,505,298	434,455	0		$10.37	Q2 2023
31 Mar 2023	1.7%	0%	$3,514,741	434,455	0		$8.09	Q1 2023
31 Dec 2022	4.5%	-2.1%	$6,842,666	434,455	-200,000	-32%	$15.75	Q4 2022
30 Sep 2022	6.6%	0%	$9,986,000	634,455	0		$15.74	Q3 2022
30 Jun 2022	6.3%	0%	$8,857,000	634,455	0		$13.96	Q2 2022
31 Mar 2022	5.9%	0%	$10,938,000	634,455	0		$17.24	Q1 2022
31 Dec 2021	3.3%	0%	$9,225,000	634,455	0		$14.54	Q4 2021
30 Sep 2021	2.3%	0%	$11,420,000	634,455	0		$18.00	Q3 2021
30 Jun 2021	1.8%	0%	$11,141,000	634,455	0		$17.56	Q2 2021
31 Mar 2021	2.9%	0%	$15,988,000	634,455	0		$25.20	Q1 2021
31 Dec 2020	0.7%	0%	$4,105,000	634,455	0		$6.47	Q4 2020
30 Sep 2020	0.52%	0%	$1,631,000	634,455	0		$2.57	Q3 2020
30 Jun 2020	0.39%	0%	$1,028,000	634,455	0		$1.62	Q2 2020
31 Mar 2020	0.29%	0%	$660,000	634,455	0		$1.04	Q1 2020
31 Dec 2019	0.46%	0%	$1,199,000	634,455	0		$1.89	Q4 2019
30 Sep 2019	0.36%	0%	$685,000	634,455	0		$1.08	Q3 2019
30 Jun 2019	0.59%	0%	$1,389,000	634,455	0		$2.19	Q2 2019
31 Mar 2019	2.9%	0%	$3,800,000	634,455	0		$5.99	Q1 2019
31 Dec 2018	4.9%	0%	$4,689,000	634,455	0		$7.39	Q4 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.